Elly A. Hassink

2.1k total citations
31 papers, 994 citations indexed

About

Elly A. Hassink is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Elly A. Hassink has authored 31 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 16 papers in Virology and 10 papers in Emergency Medicine. Recurrent topics in Elly A. Hassink's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (16 papers) and HIV-related health complications and treatments (10 papers). Elly A. Hassink is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (16 papers) and HIV-related health complications and treatments (10 papers). Elly A. Hassink collaborates with scholars based in Netherlands, Thailand and Australia. Elly A. Hassink's co-authors include Paul N.M.A. Rieu, C Festen, Peter Reiss, Gouke J. Bonsel, Cor J. Kalkman, K. Visser, Michiel A. van Agtmael, Sven A. Danner, R.S.V.M. Severijnen and Joep M. A. Lange and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Annals of Surgery.

In The Last Decade

Elly A. Hassink

29 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elly A. Hassink Netherlands 17 388 368 332 292 114 31 994
Sandy Shen Canada 6 106 0.3× 108 0.3× 100 0.3× 51 0.2× 15 0.1× 8 626
Harold S. Goldman United States 13 151 0.4× 84 0.2× 100 0.3× 32 0.1× 4 0.0× 30 628
Danielle Labbato United States 18 133 0.3× 357 1.0× 851 2.6× 355 1.2× 43 1.2k
Corrilynn O. Hileman United States 18 95 0.2× 402 1.1× 702 2.1× 366 1.3× 48 1.0k
Norma Storer United States 16 87 0.2× 333 0.9× 903 2.7× 363 1.2× 1 0.0× 27 1.1k
Sylvie Lang France 13 240 0.6× 497 1.4× 874 2.6× 355 1.2× 33 1.1k
F. Philit France 18 323 0.8× 48 0.1× 74 0.2× 18 0.1× 47 0.4× 60 1.2k
Allison C. Ross United States 11 47 0.1× 209 0.6× 512 1.5× 199 0.7× 1 0.0× 18 678
C. Greib France 12 74 0.2× 229 0.6× 232 0.7× 141 0.5× 33 524
José Pérez Rodríguez Spain 11 169 0.4× 65 0.2× 42 0.1× 17 0.1× 13 0.1× 13 539

Countries citing papers authored by Elly A. Hassink

Since Specialization
Citations

This map shows the geographic impact of Elly A. Hassink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elly A. Hassink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elly A. Hassink more than expected).

Fields of papers citing papers by Elly A. Hassink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elly A. Hassink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elly A. Hassink. The network helps show where Elly A. Hassink may publish in the future.

Co-authorship network of co-authors of Elly A. Hassink

This figure shows the co-authorship network connecting the top 25 collaborators of Elly A. Hassink. A scholar is included among the top collaborators of Elly A. Hassink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elly A. Hassink. Elly A. Hassink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picaud, Jean‐Charles, Małgorzata Arciszewska, Joaquín Escribano, et al.. (2020). An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial. Nutrients. 12(7). 2072–2072. 13 indexed citations
2.
Vonderen, Marit G. A. van, Regje M. E. Blümer, Elly A. Hassink, et al.. (2010). Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(2). 186–193. 19 indexed citations
3.
Franssen, Remco, Raaj R. Sankatsing, Elly A. Hassink, et al.. (2009). Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production. Arteriosclerosis Thrombosis and Vascular Biology. 29(9). 1336–1341. 34 indexed citations
4.
Lips, Paul, Michiel A. van Agtmael, Elly A. Hassink, et al.. (2009). First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS. 23(11). 1367–1376. 83 indexed citations
5.
Nanlohy, Nening M., Charlotte H. S. B. van den Berg, Elly A. Hassink, et al.. (2008). HCV‐specific T‐cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. Journal of Viral Hepatitis. 15(6). 409–420. 16 indexed citations
6.
7.
Autar, Reshma, Ferdinand W N M Wit, Elly A. Hassink, et al.. (2007). Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients. AIDS. 21(12). 1535–1539. 8 indexed citations
8.
Boyd, Mark, Preeyaporn Srasuebkul, Kiat Ruxrungtham, et al.. (2006). Boosted versus Unboosted Indinavir with Zidovudine and Lamivudine in Nucleoside Pre-Treated Patients: A Randomized, Open-Label Trial with 112 Weeks of Follow-Up (HIV-Nat 005). Antiviral Therapy. 11(2). 223–232. 14 indexed citations
9.
Cardiello, Peter, Elly A. Hassink, Jintanat Ananworanich, et al.. (2005). A Prospective, Randomized Trial of Structured Treatment Interruption for Patients with Chronic HIV Type 1 Infection. Clinical Infectious Diseases. 40(4). 594–600. 48 indexed citations
10.
11.
Autar, Reshma, Marta Boffito, Elly A. Hassink, et al.. (2005). Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients. Journal of Antimicrobial Chemotherapy. 56(5). 908–913. 29 indexed citations
12.
Cardiello, Peter, Elly A. Hassink, Preeyaporn Srasuebkul, et al.. (2002). Simplifying Protease Inhibitor Therapy with Once-Daily Dosing of Saquinavir Soft-Gelatin Capsules/Ritonavir (1600/100 mg): HIVNAT 001.3 Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 464–470. 44 indexed citations
13.
Rongkavilit, Chokechai, Rolf P. G. van Heeswijk, Sompop Limpongsanurak, et al.. (2002). Dose-Escalating Study of the Safety and Pharmacokinetics of Nelfinavir in HIV-Exposed Neonates. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(5). 455–463. 13 indexed citations
14.
Hassink, Elly A., et al.. (1998). Parenting children with anorectal malformations: implications and experiences. Pediatric Surgery International. 13(5-6). 377–383. 31 indexed citations
15.
Hassink, Elly A., et al.. (1996). Adults born with high anorectal atresia—How do they manage?. Diseases of the Colon & Rectum. 39(6). 695–699. 9 indexed citations
16.
Hassink, Elly A., et al.. (1996). Additional congenital defects in anorectal malformations. European Journal of Pediatrics. 155(6). 477–482. 64 indexed citations
17.
Hassink, Elly A., et al.. (1994). Quality of life after operatively corrected high anorectal malformation: A long-term follow-up study of patients aged 18 years and older. Journal of Pediatric Surgery. 29(6). 773–776. 63 indexed citations
18.
Hassink, Elly A., Liesbeth Boersma, Rein Melkert, et al.. (1993). Pulmonary morbidity 10–18 years after irradiation for Hodgkin's disease. European Journal of Cancer. 29(3). 343–347. 20 indexed citations
19.
Hassink, Elly A., et al.. (1993). Are Adults Content or Continent After Repair for High Anal Atresia? A Long-term Follow-up Study in Patients 18 Years of Age and Older. Annals of Surgery. 218(2). 196–200. 37 indexed citations
20.
Hassink, Elly A., et al.. (1992). Thyroid function 10–18 years after mantle field irradiation for Hodgkin's disease. European Journal of Cancer. 28(10). 1716–1718. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandy Shen Breakdown of academic impact, for papers by Harold S. Goldman Breakdown of academic impact, for papers by Danielle Labbato Breakdown of academic impact, for papers by Corrilynn O. Hileman Breakdown of academic impact, for papers by Norma Storer Breakdown of academic impact, for papers by Sylvie Lang Breakdown of academic impact, for papers by F. Philit Breakdown of academic impact, for papers by Allison C. Ross Breakdown of academic impact, for papers by C. Greib Breakdown of academic impact, for papers by José Pérez Rodríguez
Rankless by CCL
2026